Calendar · pharmadog

Sign In Subscribe

Date TBD

50

NOT_YET_RECRUITINGphase readoutNCT07486505: Mindfulness in Fracture Recovery and Reduction of Opioid Reliance: Evaluating the Feasibility of Implementing a Brief, Mindfulness-based Intervention to Manage Pain and Anxiety Before and After Fracture Surgery

Sponsor: McMaster University. Phase: NA. Conditions: Orthopaedic Fractures, Orthopaedic Trauma Fractures and Non-unions, Orthopaedic Trauma, Orthopaedic Surgery, Orthopaedic Related Pain (Musculoskeletal Pain), Anxiety Acute, Anxiety After Surgery, Opioid Use, Opioid Use After Surgery

full page →ctgov ↗

RECRUITINGphase readoutNCT07195994: A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

Sponsor: QuickSilver Scientific. Phase: NA. Conditions: Prediabetes / Type 2 Diabetes

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07504094: Active Coping: Interdisciplinary Program for Chronic Pain, Physiotherapy Unit (Spain)

Sponsor: Universidad de Zaragoza. Phase: NA. Conditions: Chronic Back Pain, Chronic Pain, Back Pain, Low Back Pain, Chronic, Musculoskeletal Pain, Kinesiophobia

full page →ctgov ↗

COMPLETEDphase readoutNCT02616666: A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients

Sponsor: University of Liverpool. Phase: PHASE4. Conditions: Type 2 Diabetes Mellitus

full page →ctgov ↗

RECRUITINGphase readoutNCT07206056: An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: Progressive Metastatic Castrate Resistant Prostate Cancer

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT00092222: Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Lymphoproliferative Disorder, HHV-8, Malignancy, HIV

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07556822: Phase I Study of HRS-3005 in B-cell Malignancies

Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: B-cell Malignancy

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06368622: Evolve China PMCF Study

Sponsor: Stryker Neurovascular. Phase: . Conditions: Intracranial Aneurysm

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06835751: Optimizing HIV Pre-exposure Prophylaxis (PrEP) Among Women Who Use Drugs in Tanzania

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: HIV, Mental Health, Substance Use (Drugs, Alcohol)

full page →ctgov ↗

RECRUITINGphase readoutNCT05397951: The Validation Study of Bioelectronics

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Healthy, Health Behavior

full page →ctgov ↗

RECRUITINGphase readoutNCT07142551: Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: PHASE2. Conditions: Metastatic Castration-resistant Prostate Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT07089329: Efficacy of Striatin in Malnourished Children

Sponsor: Universitas Sriwijaya. Phase: PHASE3. Conditions: Severe Acute Malnutrition

full page →ctgov ↗

RECRUITINGphase readoutNCT07504029: Human Clinical Trial Evaluating the Blood Glucose-Regulating Effects of Momordica Charantia Peptides

Sponsor: Chung Shan Medical University. Phase: NA. Conditions: People With Prediabetic

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07378553: Multiparametric Ultrafast Ultrasound Biomarkers for Duchenne and Becker Muscular Dystrophies

Sponsor: Nantes University Hospital. Phase: . Conditions: Duchene Muscular Dystrophy, Becker Muscular Dystrophy

full page →ctgov ↗

RECRUITINGphase readoutNCT07410637: Impact of Thyroid Hormones on Human Glucose and Energy Metabolism

Sponsor: University of Ulm. Phase: NA. Conditions: Graves Disease, Thyroid Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT03093337: Psychomotor Therapy for Very Premature Infants

Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Premature Infant

full page →ctgov ↗

RECRUITINGphase readoutNCT06476145: Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation

Sponsor: AdventHealth. Phase: . Conditions: Adenoma Colon Polyp

full page →ctgov ↗

RECRUITINGphase readoutNCT06665295: THRIVE-CAR-T Digital App

Sponsor: Patrick C. Johnson, MD. Phase: NA. Conditions: CAR T-Cell Therapy

full page →ctgov ↗

RECRUITINGphase readoutNCT07124377: Phenotypic Manifestations of Hereditary ATTR Amyloidosis

Sponsor: Hospital 9 de Julio de Las Breñas. Phase: . Conditions: Hereditary Amyloidosis, Transthyretin-Related

full page →ctgov ↗

COMPLETEDphase readoutNCT04985877: Effect of Fermented Milk Containing Lactobacillus Casei Strain Shirota in Sarcopenia Elderly

Sponsor: Taipei Medical University. Phase: NA. Conditions: Sarcopenia, Inflammation, Aging

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07477977: Dose for Reversal of Heparin After Cardiopulmonary Bypass

Sponsor: Sohag University. Phase: NA. Conditions: Open Heart Surgery

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06077877: A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Neoplasms

full page →ctgov ↗

RECRUITINGphase readoutNCT07313475: Evaluation of the Cryocheck HexLA Integrated TCA for the Detection of Lupus Anticoagulant

Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Lupus Anticoagulant

full page →ctgov ↗

RECRUITINGphase readoutNCT06623357: Pilot Test of Caregiver Training Protocol for Brachial Plexus Birth Injury

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.. Phase: NA. Conditions: Brachial Plexus Birth Palsy, Erbs Palsy

full page →ctgov ↗

COMPLETEDphase readoutNCT06267001: A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer (NSCLC)

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06608901: A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE2. Conditions: Sepsis-Induced Hypotension

full page →ctgov ↗

COMPLETEDphase readoutNCT05423912: Keeping on Course: A Communication-Focused Psychoeducational Program

Sponsor: Emory University. Phase: NA. Conditions: Mild Cognitive Impairment

full page →ctgov ↗

SUSPENDEDphase readoutNCT03500081: Solid Tumor Imaging MR-Linac (STIM Study)

Sponsor: Medical College of Wisconsin. Phase: . Conditions: Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT07388719: Comparison of Standard Versus Dynamic Compliance-Guided Individualized PEEP in Obese Patients Undergoing Spinal Surgery

Sponsor: Konya City Hospital. Phase: NA. Conditions: Obesity, Postoperative Pulmonary Complications, Mechanical Ventilation

full page →ctgov ↗

COMPLETEDphase readoutNCT04238819: A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Sponsor: Eli Lilly and Company. Phase: PHASE1. Conditions: Relapsed Solid Tumor, Refractory Solid Tumor

full page →ctgov ↗

RECRUITINGphase readoutNCT07416630: Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients

Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Gynecologic Cancer, Urologic Cancer, Breast Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06028828: Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

Sponsor: University of California, Irvine. Phase: PHASE2. Conditions: Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03178617: High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma

Sponsor: City of Hope Medical Center. Phase: NA. Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Lymphoblastic Lymphoma, Acute Leukemia

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07351240: The Acupuncture Treatment Effect in Patients With Schizophrenia

Sponsor: Calo Psychiatric Center. Phase: NA. Conditions: Mental Health

full page →ctgov ↗

COMPLETEDphase readoutNCT05968989: Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Influenza

full page →ctgov ↗

COMPLETEDphase readoutNCT05658068: Systems Aligning for Equity (SAFE) Spaces

Sponsor: New York University. Phase: NA. Conditions: Suicide, Mental Disorder, Mental Health, Burnout, Professional, Self Harm

full page →ctgov ↗

RECRUITINGphase readoutNCT07401550: Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.

Sponsor: University College Dublin. Phase: . Conditions: Cardiovascular Diseases (CVD), Cardiovascular Disease Prevention, Cardiovascular Disease Risk Factor, Coronary Artery Disease (CAD)

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07415291: CNN-Based AI Versus Physicians for Solitary Skin Lesion Diagnosis

Sponsor: Istanbul Training and Research Hospital. Phase: . Conditions: Solitary Skin Lesions, Skin Neoplasms, Skin Neoplasm Malignant

full page →ctgov ↗

RECRUITINGphase readoutNCT06788691: Luspatercept for Clonal Cytopenias of Uncertain Significance

Sponsor: Weill Medical College of Cornell University. Phase: PHASE2. Conditions: CCUS Clonal Cytopenia of Undetermined Significance, Anemia, Leukopenia, Thrombocytopenia, Neutropenia

full page →ctgov ↗

RECRUITINGphase readoutNCT07201974: Virtual Reality for Post-Stroke Gait Rehabilitation

Sponsor: McGill University. Phase: NA. Conditions: Stroke

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03360890: Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors

Sponsor: University of Chicago. Phase: PHASE2. Conditions: Thyroid Cancer, Salivary Gland Cancer

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07425197: Comparative Effects of Two Rehabilitation Approaches on Lumbopelvic Function in Sacroiliac Joint Dysfunction

Sponsor: Lahore University of Biological and Applied Sciences. Phase: NA. Conditions: Sacroiliac Joint Dysfunction

full page →ctgov ↗

RECRUITINGphase readoutNCT01893710: International (Pediatric) Peritoneal Biobank

Sponsor: Heidelberg University. Phase: . Conditions: Kidney Failure, Chronic, Peritoneal Dialysis Complication, Transplantation, Healthy

full page →ctgov ↗

COMPLETEDphase readoutNCT05224713: Correlations Between Press Ganey Hospital and Ambulatory Scores for a Neurosurgical Practice

Sponsor: Methodist Health System. Phase: . Conditions: Satisfaction, Patient

full page →ctgov ↗

RECRUITINGphase readoutNCT07451613: Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease

Sponsor: Leslie Thompson. Phase: PHASE1. Conditions: Huntington Disease

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03782610: Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes

Sponsor: Nationwide Children's Hospital. Phase: . Conditions: Patent Ductus Arteriosus, Preterm Infant, Bronchopulmonary Dysplasia, Neurodevelopmental Abnormality

full page →ctgov ↗

RECRUITINGphase readoutNCT07328282: Comparative Effects Between ELDOA and Spinal Mobilization With Limb Movement in Lumbar Radiculopathy

Sponsor: Foundation University Islamabad. Phase: NA. Conditions: Lumbar Radiculopathy

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07454096: Application of Radiomics for Diagnosis and Follow-up of Cardiovascular Device Infections: PREDICT Study

Sponsor: Fundacion Clinic per a la Recerca Biomédica. Phase: PHASE4. Conditions: Cardiac Disease, Device Related Infection

full page →ctgov ↗

RECRUITINGphase readoutNCT07275762: Y-4 to Treat the Postherpetic Neuralgia

Sponsor: Neurodawn Pharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: Postherpetic Neuralgia, Y-4, Pregabalin

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07422662: Arthroscopic Treatment of Acetabular Labral Lesions: Intrarticular Injection of Bone Marrow vs Hip Arthroscopy Alone

Sponsor: Istituto Ortopedico Rizzoli. Phase: NA. Conditions: FemoroAcetabular Impingement

full page →ctgov ↗

page 12 of 81